What Makes Us Different
As a next-generation CRO, our team works as an extension of your team – collaborative, critical thinking and agile. We adapt to what is needed for the industry, as we did in response to SARS-CoV-2 pandemic. Nexelis led the industry in assay development against SARS-CoV-2 in partnership with UK Health Security Agency. We accelerated development in part due to a decision to amend our business model and start the R&D necessary without client partner funding or project commitments. It is proactive decisions like this that propel us forward to offer the best solutions for our clients.
Unrivaled expertise in immunology
- Outstanding, global scientific team
- Advanced technology platforms
- Customized, state-of-the-art assay and biomarker development
- Support of FDA filings for almost 350 new molecular entities
Our Vision & Guiding Principles
Our name and symbol represent the vision and principles that guide us. As the embodiment of our corporate vision, our name and its structural components are a constant affirmation of who we are, what we do, and how we do it. From long-standing experience, we believe that success in our field is best achieved by a fusion of scientific discipline, human agility, and client partnership. Together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive.